Ligand validation:4NYQ

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 4NYQ designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4NYQ_NAG_A_206	33%	39%	0.191	0.87	1.05	1.38	1	2	0	0	100%	0.9333
8F0Y_NAG_A_202	85%	29%	0.088	0.953	0.48	2.44	-	5	0	0	100%	0.9333
7BKX_NAG_AAA_201	41%	25%	0.198	0.914	1.11	2.08	1	6	0	0	100%	0.9333
4NYR_NAG_A_205	41%	42%	0.184	0.899	0.56	1.7	-	2	0	0	100%	0.9333
8F0V_NAG_A_201	40%	57%	0.173	0.882	0.47	1.14	-	2	0	0	100%	0.9333
5EPQ_NAG_A_209	6%	46%	0.233	0.653	0.91	1.21	1	1	1	0	100%	0.9333
1OC7_NAG_A_500	100%	60%	0.04	0.991	0.61	0.9	-	1	0	0	100%	0.9333
1OC6_NAG_A_500	100%	67%	0.041	0.988	0.46	0.8	-	1	0	0	100%	0.9333
1UWC_NAG_A_262	100%	54%	0.046	0.99	0.81	0.95	-	-	0	0	100%	0.9333
6ZE6_NAG_B_703	99%	52%	0.044	0.984	0.78	1.07	-	2	0	0	100%	0.8667
6ZE2_NAG_B_704	99%	56%	0.042	0.979	0.73	0.95	-	1	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.